|
FLJ36031 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.25289999999934E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.77789999961698E-07 |
| Normal-vs-Stage2 |
1.5687200000003E-05 |
| Normal-vs-Stage3 |
1.964750E-04 |
| Normal-vs-Stage4 |
1.461990E-01 |
| Stage1-vs-Stage2 |
7.718000E-01 |
| Stage1-vs-Stage3 |
1.126550E-01 |
| Stage1-vs-Stage4 |
2.518300E-02 |
| Stage2-vs-Stage3 |
1.691760E-01 |
| Stage2-vs-Stage4 |
3.052400E-02 |
| Stage3-vs-Stage4 |
1.868150E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.5859000000027E-05 |
| Normal-vs-AfricanAmerican |
6.45590000000196E-05 |
| Normal-vs-Asian |
1.121100E-03 |
| Caucasian-vs-AfricanAmerican |
9.258400E-01 |
| Caucasian-vs-Asian |
3.064000E-01 |
| AfricanAmerican-vs-Asian |
3.767600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.21549999999127E-05 |
| Normal-vs-Female |
1.35119999999933E-06 |
| Male-vs-Female |
5.821700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.152000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.48920000001096E-06 |
| Normal-vs-Age(61-80Yrs) |
8.46290000000582E-05 |
| Normal-vs-Age(81-100Yrs) |
3.78300000000165E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.830600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.806000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.943600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.082800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.882000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.500420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.8221000000217E-06 |
| Normal-vs-Grade 2 |
2.19329999995299E-06 |
| Normal-vs-Grade 3 |
4.60290000003916E-06 |
| Normal-vs-Grade 4 |
3.342600E-01 |
| Grade 1-vs-Grade 2 |
2.494800E-01 |
| Grade 1-vs-Grade 3 |
2.150800E-01 |
| Grade 1-vs-Grade 4 |
6.843400E-03 |
| Grade 2-vs-Grade 3 |
8.222400E-01 |
| Grade 2-vs-Grade 4 |
1.892260E-02 |
| Grade 3-vs-Grade 4 |
2.448400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.44259995457941E-09 |
| Normal-vs-ccB subtype |
3.598200E-03 |
| ccA subtype-vs-ccB subtype |
1.69420000251108E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.793240E-04 |
| Normal-vs-N1 |
2.016400E-01 |
| N0-vs-N1 |
5.149000E-01 |
|
|
